Indicator Explainer
MET Gene
This gene plays a regulatory role in the modulation of cell-surface receptors and hepatocyte growth factor interactions.
This page explains what the indicator is and how results are interpreted in general terms. Reference ranges depend on the laboratory, the method, and your own situation — no single “normal value” applies to everyone. This page is health information, not a diagnosis. For symptoms, treatment, or urgent concerns, contact a healthcare professional.
When it is tested
Source: National Cancer Institute, NCI Thesaurus 26.09d, C18325. NCI definition, reproduced without modification under CC BY 4.0. Source identity and definition checked automatically on 2026-10-19. No individual clinical interpretation or human reviewer is asserted.
Reading results
Reference intervals and interpretation depend on the laboratory, specimen, method and clinical context. This source definition is educational information; it does not establish a diagnosis, product approval or suitability for an individual.
Also Known As
References
- NCI Thesaurus 26.09d — MET Gene (C18325)
- Source: National Cancer Institute, NCI Thesaurus 26.09d, C18325. NCI definition, reproduced without modification under CC BY 4.0.
- Bilateral breast metastatic rectal cancer with MET gene amplification: A rare case report. — Rare Tumors, 2026-09-03 (PMID 42699016; literature)
- Exploring the Role of MET Gene as a Potential Biomarker and Therapeutic Target in Ampullary Cancer. — Pancreas, 2026-06-25 (PMID 42348518; literature)
- Spitz tumours with MET gene fusions: 17 cases with identifiable histomorphological and genetic features. — Pathology, 2026-09-09 (PMID 42869762; literature)
- Association of MET gene polymorphisms with breast cancer risk in Nigerian patients: a case-control study. — BMC Cancer, 2026-03-14 (PMID 41832464; literature)
- Fusion Gene EPHB4-MET Driven by HOXA9 and Exerted Oncogenic Activity in Non-Small Cell Lung Cancer. — Crit Rev Immunol, 2026-01-01 (PMID 42224677; literature)
- The Mutation Patterns of MET Gene in Lung Cancer and Brain Tumors: Clinical and Therapeutic Implications. — Cancer Med, 2026-01-01 (PMID 41521799; literature)